Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
4
5
6
7
8
10
11
12
12:00 AM - PFF Summit 2015
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
6
NextEdge Health Experience Summit
2015-11-03 - 2015-11-04    
All Day
With a remarkable array of speakers and panelists, the Next Edge: Health Experience Summit is shaping-up to be an event that attracts healthcare professionals who [...]
mHealthSummit 2015
2015-11-08 - 2015-11-11    
All Day
Anytime, Anywhere: Engaging Patients and ProvidersThe 7th annual mHealth Summit, which is now part of the HIMSS Connected Health Conference, puts new emphasis on innovation [...]
24th Annual Healthcare Conference
2015-11-09 - 2015-11-11    
All Day
The Credit Suisse Healthcare team is delighted to invite you to the 2015 Healthcare Conference that takes place November 9th-11th in Arizona. We have over [...]
PFF Summit 2015
2015-11-12 - 2015-11-14    
All Day
PFF Summit 2015 will be held at the JW Marriott in Washington, DC. Presented by Pulmonary Fibrosis Foundation Visit the www.pffsummit.org website often for all [...]
2nd International Conference on Gynecology & Obstetrics
2015-11-16 - 2015-11-18    
All Day
Welcome Message OMICS Group is esteemed to invite you to join the 2nd International conference on Gynecology and Obstetrics which will be held from November [...]
Events on 2015-11-03
NextEdge Health Experience Summit
3 Nov 15
Philadelphia
Events on 2015-11-08
mHealthSummit 2015
8 Nov 15
National Harbor
Events on 2015-11-09
Events on 2015-11-12
PFF Summit 2015
12 Nov 15
Washington, DC
Events on 2015-11-16
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.